Structural Determinants of Cisplatin and Transplatin Binding to the Met-Rich Motif of Ctr1: A Computational Spectroscopy Approach-Reference-Cited by-同舟云学术

Structural Determinants of Cisplatin and Transplatin Binding to the Met-Rich Motif of Ctr1: A Computational Spectroscopy Approach

Published:2012-07-03 Issue:8 Volume:8 Page:2912-2920
ISSN:1549-9618
Container-title:Journal of Chemical Theory and Computation
language:en
Short-container-title:J. Chem. Theory Comput.

Author:

Nguyen Trung Hai¹,Arnesano Fabio²,Scintilla Simone²,Rossetti Giulia¹,Ippoliti Emiliano¹,Carloni Paolo¹³,Natile Giovanni²

Affiliation:

1. Computational Biophysics, German Research School for Simulation Sciences, D-52425 Jülich, Germany, and Institute for Advanced Simulation, Forschungszentrum Jülich, D-52425 Jülich, Germany

2. Department Farmaco-Chimico, University of Bari “A. Moro”, via Edoardo Orabona 4, 70125 Bari, Italy

3. Statistical and Biological Physics Sector, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Via Bonomea 265, I-34136 Trieste, Italy

Publisher

American Chemical Society (ACS)

Subject

Physical and Theoretical Chemistry,Computer Science Applications

Link

https://pubs.acs.org/doi/pdf/10.1021/ct300167m

Reference97 articles.

1. The resurgence of platinum-based cancer chemotherapy

2. The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy

3. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs

4. The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In defense of platinum: Amino acidic polydentate ligands as a shield against sulphur-donor nucleophilic attacks;Inorganica Chimica Acta;2024-09

2. Unraveling Copper Exchange in the Atox1-Cu(I)-Mnk1 Heterodimer: A Simulation Approach;The Journal of Physical Chemistry B;2024-05-23

3. The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives;Molecules;2023-04-12

4. The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake;Bioinorganic Chemistry and Applications;2022-12-30

5. Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities;Dalton Transactions;2022